Search results
Does Soaring Novavax Stock Have Enough Fuel to Climb Higher? | The Motley Fool
The Motley Fool· 7 days agoThe market was responding to terrific news from Sanofi (NASDAQ: SNY), a global pharmaceutical giant...
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 3 days agoPfizer-BioNtech, Moderna and Novavax all have updated versions of the vaccine and are safe for use....
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 1 day agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell? | The Motley Fool
The Motley Fool· 5 days agoNovavax (NVAX -4.30%) took a turn in the investor spotlight in early May, when the vaccine...
Novavax Stock Just Tripled. Is It Too Late to Buy?
The Motley Fool via AOL· 6 days agoSo, it's no surprise that such news prompted some investors to pile into the stock. But does this rapid gain mean it's too late to buy Novavax shares now...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 3 days agoSanofi will also be able to use Novavax's Matrix-M adjuvant to develop its own products. It will...about in the long run? Novavax isn't in imminent...
Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
FX Empire via Yahoo Finance· 6 days agoThe past five days have been a rollercoaster for Novavax investors, as the share price of the...
Roaring Kitty's Rally Cry: 3 Meme Stocks to Pounce On Now
InvestorPlace· 6 hours agoGameStop (NYSE:GME) and AMC (NYSE:AMC) meme stocks rose substantially last week, gaining over 70%. The return of ‘Roaring Kitty’, prominent investor Keith Gill, has traders wondering which meme ...
The Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Zacks via Yahoo Finance· 3 days ago(See the last biotech stock roundup here: Biotech Stock Roundup: GILD’s GSK’ Q1 Earnings, DCPH Soars...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 6 days agoWhat's After Covid Shots? Investors are paying close attention to the bespoke cancer vaccine in...
